168 related articles for article (PubMed ID: 23752066)
1. The natural product honokiol inhibits calcineurin inhibitor-induced and Ras-mediated tumor promoting pathways.
Banerjee P; Basu A; Arbiser JL; Pal S
Cancer Lett; 2013 Sep; 338(2):292-9. PubMed ID: 23752066
[TBL] [Abstract][Full Text] [Related]
2. Honokiol inhibits c-Met-HO-1 tumor-promoting pathway and its cross-talk with calcineurin inhibitor-mediated renal cancer growth.
Balan M; Chakraborty S; Flynn E; Zurakowski D; Pal S
Sci Rep; 2017 Jul; 7(1):5900. PubMed ID: 28724911
[TBL] [Abstract][Full Text] [Related]
3. Calcineurin inhibitors activate the proto-oncogene Ras and promote protumorigenic signals in renal cancer cells.
Datta D; Contreras AG; Basu A; Dormond O; Flynn E; Briscoe DM; Pal S
Cancer Res; 2009 Dec; 69(23):8902-9. PubMed ID: 19903851
[TBL] [Abstract][Full Text] [Related]
4. Calcineurin inhibitor-induced and Ras-mediated overexpression of VEGF in renal cancer cells involves mTOR through the regulation of PRAS40.
Basu A; Banerjee P; Contreras AG; Flynn E; Pal S
PLoS One; 2011; 6(8):e23919. PubMed ID: 21886838
[TBL] [Abstract][Full Text] [Related]
5. Roles of the Hsp90-Calcineurin Pathway in the Antifungal Activity of Honokiol.
Liao K; Sun L
J Microbiol Biotechnol; 2018 Jul; 28(7):1086-1093. PubMed ID: 29913547
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of a combination therapy using calcineurin inhibitor and mTOR inhibitor in preventing allograft rejection and post-transplantation renal cancer progression.
Basu A; Liu T; Banerjee P; Flynn E; Zurakowski D; Datta D; Viklicky O; Gasser M; Waaga-Gasser AM; Yang J; Pal S
Cancer Lett; 2012 Aug; 321(2):179-86. PubMed ID: 22343319
[TBL] [Abstract][Full Text] [Related]
7. Honokiol suppresses survival signals mediated by Ras-dependent phospholipase D activity in human cancer cells.
Garcia A; Zheng Y; Zhao C; Toschi A; Fan J; Shraibman N; Brown HA; Bar-Sagi D; Foster DA; Arbiser JL
Clin Cancer Res; 2008 Jul; 14(13):4267-74. PubMed ID: 18594009
[TBL] [Abstract][Full Text] [Related]
8. Calpain/SHP-1 interaction by honokiol dampening peritoneal dissemination of gastric cancer in nu/nu mice.
Liu SH; Wang KB; Lan KH; Lee WJ; Pan HC; Wu SM; Peng YC; Chen YC; Shen CC; Cheng HC; Liao KK; Sheu ML
PLoS One; 2012; 7(8):e43711. PubMed ID: 22937084
[TBL] [Abstract][Full Text] [Related]
9. The natural product honokiol preferentially inhibits cellular FLICE-inhibitory protein and augments death receptor-induced apoptosis.
Raja SM; Chen S; Yue P; Acker TM; Lefkove B; Arbiser JL; Khuri FR; Sun SY
Mol Cancer Ther; 2008 Jul; 7(7):2212-23. PubMed ID: 18645030
[TBL] [Abstract][Full Text] [Related]
10. Honokiol augments the anti-cancer effects of oxaliplatin in colon cancer cells.
Hua H; Chen W; Shen L; Sheng Q; Teng L
Acta Biochim Biophys Sin (Shanghai); 2013 Sep; 45(9):773-9. PubMed ID: 23786838
[TBL] [Abstract][Full Text] [Related]
11. Altered VEGF mRNA stability following treatments with immunosuppressive agents: implications for cancer development.
Basu A; Datta D; Zurakowski D; Pal S
J Biol Chem; 2010 Aug; 285(33):25196-202. PubMed ID: 20554520
[TBL] [Abstract][Full Text] [Related]
12. Novel roles of c-Met in the survival of renal cancer cells through the regulation of HO-1 and PD-L1 expression.
Balan M; Mier y Teran E; Waaga-Gasser AM; Gasser M; Choueiri TK; Freeman G; Pal S
J Biol Chem; 2015 Mar; 290(13):8110-20. PubMed ID: 25645920
[TBL] [Abstract][Full Text] [Related]
13. Disruption of cooperation between Ras and MycN in human neuroblastoma cells promotes growth arrest.
Yaari S; Jacob-Hirsch J; Amariglio N; Haklai R; Rechavi G; Kloog Y
Clin Cancer Res; 2005 Jun; 11(12):4321-30. PubMed ID: 15958613
[TBL] [Abstract][Full Text] [Related]
14. Honokiol is a FOXM1 antagonist.
Halasi M; Hitchinson B; Shah BN; Váraljai R; Khan I; Benevolenskaya EV; Gaponenko V; Arbiser JL; Gartel AL
Cell Death Dis; 2018 Jan; 9(2):84. PubMed ID: 29367668
[TBL] [Abstract][Full Text] [Related]
15. Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1.
Rajendran P; Li F; Shanmugam MK; Vali S; Abbasi T; Kapoor S; Ahn KS; Kumar AP; Sethi G
J Cell Physiol; 2012 May; 227(5):2184-95. PubMed ID: 21792937
[TBL] [Abstract][Full Text] [Related]
16. Honokiol inhibits in vitro and in vivo growth of oral squamous cell carcinoma through induction of apoptosis, cell cycle arrest and autophagy.
Huang KJ; Kuo CH; Chen SH; Lin CY; Lee YR
J Cell Mol Med; 2018 Mar; 22(3):1894-1908. PubMed ID: 29363886
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanism of inhibition of the abnormal proliferation of human umbilical vein endothelial cells by hydroxysafflor-yellow A.
Wang J; Wang J; Wang X; Liu L; Hu J; Yu X; Xu Y; Niu X; Lin Z; Zhang Y; Zhang X; Zhang Q
Pharm Biol; 2016 Sep; 54(9):1800-7. PubMed ID: 26730646
[TBL] [Abstract][Full Text] [Related]
18. Honokiol potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through modulation of nuclear factor-kappaB activation pathway.
Ahn KS; Sethi G; Shishodia S; Sung B; Arbiser JL; Aggarwal BB
Mol Cancer Res; 2006 Sep; 4(9):621-33. PubMed ID: 16966432
[TBL] [Abstract][Full Text] [Related]
19. Honokiol inhibits H(2)O(2)-induced apoptosis in human lens epithelial cells via inhibition of the mitogen-activated protein kinase and Akt pathways.
Tang X; Yao K; Zhang L; Yang Y; Yao H
Eur J Pharmacol; 2011 Jan; 650(1):72-8. PubMed ID: 20965163
[TBL] [Abstract][Full Text] [Related]
20. Honokiol induces apoptosis and suppresses migration and invasion of ovarian carcinoma cells via AMPK/mTOR signaling pathway.
Lee JS; Sul JY; Park JB; Lee MS; Cha EY; Ko YB
Int J Mol Med; 2019 May; 43(5):1969-1978. PubMed ID: 30864681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
